Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Post Chronic Pancreatitis Diabetes Mellitus
NCT06937294Phase 4Recruiting
- Sponsor
- Changhai Hospital
- Start
- Apr 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in diabetes mellitus due to chronic pancreatitis (T3cDM), sponsored by Changhai Hospital. Started Apr 2025; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
diabetes mellitus due to chronic pancreatitis (T3cDM)
Beyond the preview
Go deeper on NCT06937294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06937294.